Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Raphael E. Szalat"'
Autor:
Moritz Binder, Raphael E. Szalat, Srikanth Talluri, Mariateresa Fulciniti, Hervé Avet-Loiseau, Giovanni Parmigiani, Mehmet K. Samur, Nikhil C. Munshi
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract The natural history of multiple myeloma is characterized by its localization to the bone marrow and its interaction with bone marrow stromal cells. The bone marrow stromal cells provide growth and survival signals, thereby promoting the deve
Externí odkaz:
https://doaj.org/article/9ae3e3ccba2e4821b3f01ffba88946f8
Autor:
Joshua N. Gustine, Raphael E. Szalat, Andrew Staron, Tracy Joshi, Lisa Mendelson, J. Mark Sloan, Vaishali Sanchorawala
Publikováno v:
Haematologica, Vol 108, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/e326eddab0914ffc9ff75e4ddccc7bd0
Autor:
Mariateresa Fulciniti, Charles Y. Lin, Mehmet K. Samur, Michael A. Lopez, Irtisha Singh, Matthew A. Lawlor, Raphael E. Szalat, Christopher J. Ott, Herve’ Avet-Loiseau, Kenneth C. Anderson, Richard A. Young, James E. Bradner, Nikhil C. Munshi
Publikováno v:
Cell Reports, Vol 25, Iss 13, Pp 3693-3705.e6 (2018)
Summary: The relationship between promoter proximal transcription factor-associated gene expression and super-enhancer-driven transcriptional programs are not well defined. However, their distinct genomic occupancy suggests a mechanism for specific a
Externí odkaz:
https://doaj.org/article/32241953d32f40a8b2c48b196d12a4b9
Autor:
Nathanael R. Fillmore, Raphael E. Szalat, Jennifer La, Westyn Branch-Elliman, Paul A. Monach, Vinh Nguyen, Mehmet K. Samur, Mary T. Brophy, Nhan V. Do, Nikhil C. Munshi
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Autor:
Joshua N. Gustine, Andrew Staron, Raphael E. Szalat, Lisa M. Mendelson, Tracy Joshi, Frederick L. Ruberg, Omar Siddiqi, Deepa M. Gopal, Camille V. Edwards, Andrea Havasi, Michelle Kaku, K. H. Vincent Lau, John L. Berk, J. Mark Sloan, Vaishali Sanchorawala
Publikováno v:
American journal of hematologyREFERENCES. 97(9)
High-dose melphalan and stem cell transplantation (HDM/SCT) is an effective treatment for selected patients with AL amyloidosis. We report the long-term outcomes of 648 patients with AL amyloidosis treated with HDM/SCT over 25 years. Hematologic CR w